BioMedPartners is a leading Swiss Life Science VC investing in innovative early-stage human Life Science companies that address important medical needs with novel technologies or products backed by compelling science. The firm focuses on Switzerland and surrounding EU countries, primarily investing in drug development, diagnostics, and medical technology.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions